In detail, these authors have hypothesized that a defect in tumor Ctr1 expression is associated with reduced tissue Pt accumulation and tumor response in NSCLC following Pt-based chemotherapy. This evidence concerns the gene SLC31A1 and non-small cell lung carcinoma.